These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5343357)

  • 1. The metabolism of orally administered L-Dopa in Parkinsonism.
    Calne DB; Karoum F; Ruthven CR; Sandler M
    Br J Pharmacol; 1969 Sep; 37(1):57-68. PubMed ID: 5343357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m-Hydroxyphenylacetic acid formation from L-dopa in man: suppression by neomycin.
    Sandler M; Karoum F; Ruthven CR; Calne DB
    Science; 1969 Dec; 166(3911):1417-8. PubMed ID: 5350345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple and rapid gas chromatography for determining 3,4-dihydroxyphenylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid in urine from patients with parkinsonism treated with L-3,4-dihydroxyphenylalanine.
    Fukaya J; Imai K; Tamura Z
    Clin Chim Acta; 1971 Jul; 33(2):470-2. PubMed ID: 5119325
    [No Abstract]   [Full Text] [Related]  

  • 4. The excretion of L-dopa metabolites at different hours of the day.
    Aguggini G; Meucci M; Reina G
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):749-57. PubMed ID: 4629113
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitive determination of tyrosine metabolites, p-hydroxyphenylacetic acid, 4-hydroxy-3-methoxyphenyl-acetic acid and 4-hydroxy-3-methoxymandelic acid, by gas chromatography-negative-ion chemical-ionization mass spectrometry. Application to a stable isotope-labelled tracer experiment to investigate their metabolism in man.
    Shimamura M; Kamada S; Hayashi T; Naruse H; Iida Y
    J Chromatogr; 1986 Jan; 374(1):17-26. PubMed ID: 3753983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
    Routh JI; Bannow RE; Fincham RW; Stoll JL
    Clin Chem; 1971 Sep; 17(9):867-71. PubMed ID: 5571485
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical investigations in patients with Parkinson's disease treated with L-dopa.
    Jequier E; Dufresne JJ
    Neurology; 1972 Jan; 22(1):15-21. PubMed ID: 5061836
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of 3, 4-dihydroxyphenylalanine, its metabolites and analogues in vivo in the rat: urinary excretion pattern.
    Goodwin BL; Ruthven CR; King GS; Sandler M
    Xenobiotica; 1978 Oct; 8(10):629-51. PubMed ID: 716472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
    Uono M; Tanabe H; Yano Y; Nakao K
    No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082
    [No Abstract]   [Full Text] [Related]  

  • 10. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
    Matlina ESh; Kandel' EI; Vasil'ev VN; Iadgarov IS; Bol'shakova TD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous quantitation of 4-hydroxy-3-methoxymandelic (vanilmandelic) and 4-hydroxy-3-methoxyphenylacetic (homovanillic) acids in human urine.
    Addanki A; Hinnenkamp ER; Sotos JF
    Clin Chem; 1976 Mar; 22(3):310-4. PubMed ID: 1253406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas chromatographic estimation of urinary homovanillic and 4-hydroxy-3-methoxymandelic acids using capillary columns.
    Goodwin BL; Ruthven CR; Sandler M
    Clin Chim Acta; 1974 Aug; 55(1):111-2. PubMed ID: 4413535
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of dopa in Parkinsonism.
    Sandler M; Karoum F; Ruthven CR
    N Engl J Med; 1969 Dec; 281(25):1429. PubMed ID: 5355467
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
    Imai K; Sugiura M; Kubo H; Tamura Z; Oya K
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):759-64. PubMed ID: 5045616
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease.
    Tyce GM; Muenter MD; Owen CA
    Mayo Clin Proc; 1970 Sep; 45(9):645-56. PubMed ID: 5311767
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine (3-hydroxytyramine) metabolism in parkinsonism.
    Goodall M; Alton H
    J Clin Invest; 1969 Dec; 48(12):2300-8. PubMed ID: 5355341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3,5-Trihydroxyphenylacetic acid. A metabolite of L-3,4-dihydroxyphenylalanine.
    Wada GH; Fellman JH
    Biochemistry; 1973 Dec; 12(25):5212-7. PubMed ID: 4799943
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 20. Tyrosine metabolism: urinary excretion studies in Parkinsonism.
    Szpunar WE; Ericsson AD; McCann DS
    Clin Chim Acta; 1971 Nov; 35(1):209-17. PubMed ID: 5126994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.